These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25519964)

  • 21. Therapeutic trials on progressive muscular dystrophy.
    Satoyoshi E
    Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Directory of registries of clinical trials.
    Easterbrook PJ
    Stat Med; 1992 Feb; 11(3):345-59. PubMed ID: 1609175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.
    Nurok M; Eslick I; Carvalho CR; Costabel U; D'Armiento J; Glanville AR; Harari S; Henske EP; Inoue Y; Johnson SR; Lacronique J; Lazor R; Moss J; Ruoss SJ; Ryu JH; Seyama K; Watz H; Xu KF; Hohmann EL; Moss F
    Lymphat Res Biol; 2010 Mar; 8(1):81-7. PubMed ID: 20235890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social involvement issues in patients with Becker muscular dystrophy: A questionnaire survey of subjects from a patient registry.
    Mori-Yoshimura M; Mizuno Y; Yoshida S; Minami N; Yonemoto N; Takeuchi F; Nishino I; Murata M; Takeda S; Takahashi Y; Kimura E
    Brain Dev; 2018 Apr; 40(4):268-277. PubMed ID: 29196072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology of progressive muscular dystrophy in selected regions of Poland].
    Stepniak U
    Neurol Neurochir Pol; 1985; 19(5):369-74. PubMed ID: 3831791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques.
    Nakagawa M; Nakahara K; Yoshidome H; Suehara M; Higuchi I; Fujiyama J; Nakamura A; Kubota R; Takenaga S; Arahata K
    Neuroepidemiology; 1991; 10(4):185-91. PubMed ID: 1745328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
    Rodrigues M; Yokota T
    Methods Mol Biol; 2018; 1828():31-55. PubMed ID: 30171533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.
    Mah JK; Korngut L; Fiest KM; Dykeman J; Day LJ; Pringsheim T; Jette N
    Can J Neurol Sci; 2016 Jan; 43(1):163-77. PubMed ID: 26786644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Why multi-national clinical trials now?--Industry perspective].
    Miki S
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):293-6. PubMed ID: 17301547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The problems of clinical trials and registries in rare diseases.
    Luisetti M; Campo I; Scabini R; Zorzetto M; Kadija Z; Mariani F; Ferrarotti I
    Respir Med; 2010 Jul; 104 Suppl 1():S42-4. PubMed ID: 20413285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autosomal recessive distal muscular dystrophy--a new type of distal muscular dystrophy observed characteristically in Japan].
    Miyoshi K; Iwasa M; Kawai H; Sasaki N; Kusaka K; Yagita M; Hiasa M; Tada Y
    Nihon Rinsho; 1977 Nov; 35(11):3922-8. PubMed ID: 599673
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epidemiological study of progressive muscular dystrophy].
    Goto K
    Kango Gijutsu; 1971 Mar; 17(3):90-9. PubMed ID: 5205332
    [No Abstract]   [Full Text] [Related]  

  • 33. [Status and registration of patients with progressive muscular dystrophy in the GDR (German Democratic Republic)].
    Kressin W
    Beitr Orthop Traumatol; 1975 Jan; 22(1):47-8. PubMed ID: 1122239
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased incidence of Duchenne muscular dystrophy in western Japan 1956-1980.
    Takeshita K; Kasagi S; Mito T; Tanaka T; Ootani K
    Neuroepidemiology; 1987; 6(3):130-8. PubMed ID: 3658082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The New Zealand Neuromuscular Disease Registry: rate of diagnoses confirmed by molecular testing.
    Rodrigues M; Kidd A; Love DR; Roxburgh R
    J Clin Neurosci; 2015 Feb; 22(2):434-6. PubMed ID: 25443090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.
    Ito T
    PLoS One; 2016; 11(2):e0148455. PubMed ID: 26848574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of Duchenne type and congenital type of muscular dystrophy in Shimane, Japan.
    Takeshita K; Yoshino K; Kitahara T; Nakashima T; Kato N
    Jinrui Idengaku Zasshi; 1977 Jun; 22(1):43-7. PubMed ID: 926418
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Trials in Dentistry: A Cross-sectional Analysis of World Health Organization-International Clinical Trial Registry Platform.
    Sivaramakrishnan G; Sridharan K
    J Evid Based Dent Pract; 2016 Jun; 16(2):90-5. PubMed ID: 27449835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Present status of progressive muscular dystrophy].
    Koyama N
    Iryo; 1967 Jul; 21(7):779-85. PubMed ID: 5582472
    [No Abstract]   [Full Text] [Related]  

  • 40. An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry.
    Woodward L; Johnson S; Walle JV; Beck J; Gasteyger C; Licht C; Ariceta G;
    Orphanet J Rare Dis; 2016 Nov; 11(1):154. PubMed ID: 27871301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.